Michelle Ostrander, PhD, Product Manager, Medical Technology Directory

Recent Posts

NPR Segment Features Treatments for Low Back Pain

Last week, as part of their “Your Health” segment, NPR aired a piece about the effectiveness of various treatments for low back pain, with a focus on spinal manipulation. Lower back pain is a common complaint to physicians, and, as the article states, a common reason for the prescription of addictive narcotic painkillers. Other interventions can include:

  • Acupuncture
  • Physical therapy
  • Massage therapy
  • Nonsteroidal anti-inflammatory drugs (NSAIDS)
  • Chiropractic treatment
Read More

Topics: Payers, Hospitals, Hayes Blog, Devices, Health Technology Assessments,

Top 3 Hayes Reports: 1st Quarter, 2017

Who doesn’t love lists? Especially lists detailing the best of the best, the most popular, the most in-demand. To that end, we’ve compiled a list of our top three Directory reports for the first three months of the year, in order of retrievals from our Knowledge Center. These three represent a mix of information important to both payers and providers.

If you’re already a subscriber, you can check out these reports at any time. If you’re not a Hayes member…what are you waiting for? Don’t forget, you can also purchase an individual report. Contact us to find out how.

Let’s get to the top three!

Read More

Topics: Payers, Hospitals, Hayes Blog, Health Technology Assessments,

New Methodology Webinar Focuses on Supply Chain and Value Analysis

Despite the possibility of impending changes to current healthcare regulations, it appears, at least for the moment, that value-based purchasing and bundled payment plans are here to stay. As a result, hospitals and health systems must scrutinize their decision-making processes around health technology acquisitions, product standardization, and utilization management. As part of that process, it is incumbent upon both supply chain/value analysis professionals and clinicians to consider three important questions:

Read More

Topics: Hospitals, Hayes Blog, Health Technology Assessments,

JAMA: Sepsis Responsible for Highest Rate of Hospital Readmissions

Last week, the Journal of the American Medical Association (JAMA) released a report about research performed at the University Of Pittsburgh School Of Medicine and the VA Pittsburgh Healthcare System. The findings revealed that sepsis, a potentially fatal condition triggered by an infection in the bloodstream, has a greater readmission rate (12.2%) than all four of the medical conditions currently tracked by the Centers for Medicare & Medicaid Services (CMS). Those conditions are:

Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence, Medicare

Evidence Key to CMS dollars for Hospital Acquired Conditions

As part of the Patient Protection and Affordable Care Act (ACA), the Hospital-Acquired Condition Reduction Program (HACRP) was established to incentivize hospitals to reduce the number of HAC’s per year (Source:www.cms.gov). HAC’s differ slightly from hospital-acquired infections (HAI’s) although both designations fall under the regulations set forth by the HACRP.

  • HAI’s: infections patients may contract while under treatment in a healthcare facility (urinary tract infections, sepsis, etc).
  • HAC’s: any other situation or condition that may occur (including medication errors, pressure sores, falls).
Read More

Topics: Hospitals, Hayes Blog, Healthcare Evidence, Medicare, Consumers

Specialty Pharma: A Prescription for Controlling Catastrophic Costs

Serving nearly 85% of the health plan market’s covered lives, Hayes makes it a priority to stay in touch with clients about what keeps them up at night. With a variety of plans all over the nation varying in size and product offerings, you can imagine we hear a lot of concerns. One of the recurring themes we hear is specialty pharmaceuticals. In fact, we have heard so much on the topic, it has been included as an accredited session at our Hayes Client Symposium this September.

Read More

Sign up to receive updates from our blog

Our latest articles

New Call-to-action